Partial Thromboplastin Time (PTT)
Lipase, Serum
Congestive cardiomyopathy
Bilirubin Total, Serum
Comprehensive Metabolic Panel
Multi Gene Methylation Assay for Hepatocellular Carcinoma by NGS (HelioLiver™, HelioHCC™ Trace, EarlyDx MethylScan™)
Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
Cytochrome P450 2A6 (CYP2A6) Genotyping
Coagulation Factor VIII Activity Assay, Plasma
Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, GENESEEQPRIME™, Plasma Complete™)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Medical Test
Clinical Utility
Access to
Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
is restricted.
Sign up now
Loading...